TickerFacts.

LB Pharmaceuticals Inc (LBRX): Shareholders' Equity

Annual figures by period end, from SEC filings.

$301.31M
As of 2025-12-31
$332.35M
As of 2026-06-30
2024-12-31: -$94.55M2025-12-31: $301.31M$301.31M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$301.31Mn/m2026-03-26, Balance as of period end
2024-12-31-$94.55Mn/a2026-03-26, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
LB Pharmaceuticals Inc (LBRX)2025-12-31$301.31Mn/m
Atea Pharmaceuticals, Inc. (AVIR)2025-12-31$275.43M-37.2%
ADC Therapeutics SA (ADCT)2025-12-31-$185.83Mn/m
Omeros Corp (OMER)2025-12-31-$121.23Mn/m
Sionna Therapeutics, Inc. (SION)2025-12-31$306.83Mn/m
Prothena Corp Public Ltd Co (PRTA)2025-12-31$280.47M-42.4%
ARS Pharmaceuticals, Inc. (SPRY)2025-12-31$114.26M-55.5%
Liquidia Corp (LQDA)2025-12-31$44.75M-43.6%
Cartesian Therapeutics, Inc. (RNAC)2025-12-31-$126.24Mn/m

Compare LBRX, AVIR, ADCT, OMER side by side · Screen every company in Pharmaceutical Preparations ↗